Emerging from the global pandemic, the Asia Pacific healthcare system is evolving in reaction to overcrowding and growing expenses. 2023 was a pivotal year which witnessed shifting patient needs as well as deeper integration of advanced technology such as GenAI.

In 2024, life sciences organizations will continue to undergo significant changes while creating new opportunities for more effective business strategy and stakeholder engagement.

Download the white paper as IQVIA experts identify 6 key trends and shifts to anticipate across the Asia healthcare and life sciences sector in the year ahead.

For more information, contact us.

• Nikhil Khicha, Managing Principal, SEA & APAC RHQ
• Rijul Bhardwaj, Associate Principal, Strategy & Management Consulting
• Vanessa How, Consultant, Strategy & Management Consulting
• Dineta Oki, Associate Consultant, Strategy & Management Consulting
• Yi Shi, Analyst, Strategy & Management Consulting